These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32467507)

  • 1. Novel Anti-Hexokinase 1 Antibodies Are Associated With Poor Prognosis in Patients With Primary Biliary Cholangitis.
    Reig A; Norman GL; Garcia M; Shums Z; Ruiz-Gaspà S; Bentow C; Mahler M; Romera MA; Vinas O; Pares A
    Am J Gastroenterol; 2020 Oct; 115(10):1634-1641. PubMed ID: 32467507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-kelch-like 12 and anti-hexokinase 1: novel autoantibodies in primary biliary cirrhosis.
    Norman GL; Yang CY; Ostendorff HP; Shums Z; Lim MJ; Wang J; Awad A; Hirschfield GM; Milkiewicz P; Bloch DB; Rothschild KJ; Bowlus CL; Adamopoulos IE; Leung PS; Janssen HJ; Cheung AC; Coltescu C; Gershwin ME
    Liver Int; 2015 Feb; 35(2):642-51. PubMed ID: 25243383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of anti-kelch-like 12 and anti-hexokinase 1 antibodies in primary biliary cholangitis patients in China.
    Liu ZY; Xu L; Liu B
    Rev Esp Enferm Dig; 2021 Aug; 113(8):585-590. PubMed ID: 33307711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a novel extended automated particle-based multi-analyte assay for the detection of autoantibodies in the diagnosis of primary biliary cholangitis.
    Villalta D; Seaman A; Tiongson M; Warren C; Bentow C; Bizzaro N; Alessio MG; Porcelli B; Norman GL; Mahler M
    Clin Chem Lab Med; 2020 Aug; 58(9):1499-1507. PubMed ID: 32286240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prevalence of Anti-Hexokinase-1 and Anti-Kelch-Like 12 Peptide Antibodies in Patients With Primary Biliary Cholangitis Is Similar in Europe and North America: A Large International, Multi-Center Study.
    Norman GL; Reig A; Viñas O; Mahler M; Wunsch E; Milkiewicz P; Swain MG; Mason A; Stinton LM; Aparicio MB; Aldegunde MJ; Fritzler MJ; Parés A
    Front Immunol; 2019; 10():662. PubMed ID: 31001269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic significance of autoantibodies in patients with primary biliary cirrhosis].
    Xiao H; Chen JW; Xie X; Liu YM; Li F
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):209-14. PubMed ID: 22516989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of primary biliary cirrhosis and disease-associated autoantibodies in Japanese patients with systemic sclerosis.
    Imura-Kumada S; Hasegawa M; Matsushita T; Hamaguchi Y; Encabo S; Shums Z; Norman GL; Takehara K; Fujimoto M
    Mod Rheumatol; 2012 Nov; 22(6):892-8. PubMed ID: 22327744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antinuclear autoantibodies Sp100 and gp210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis.
    Luettig B; Boeker KH; Schoessler W; Will H; Loges S; Schmidt E; Worman HJ; Gershwin ME; Manns MP
    J Hepatol; 1998 May; 28(5):824-8. PubMed ID: 9625318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary biliary cirrhosis-related autoantibodies in a large cohort of italian patients with systemic sclerosis.
    Cavazzana I; Ceribelli A; Taraborelli M; Fredi M; Norman G; Tincani A; Satoh M; Franceschini F
    J Rheumatol; 2011 Oct; 38(10):2180-5. PubMed ID: 21921093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of primary biliary cholangitis with ursodeoxycholic acid, prednisolone and immunosuppressants in patients not responding to ursodeoxycholic acid alone and the prognostic indicators.
    Qian JD; Yao TT; Wang Y; Wang GQ
    Clin Res Hepatol Gastroenterol; 2020 Nov; 44(6):874-884. PubMed ID: 32305248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic accuracy of biomarkers for diagnosis of primary biliary cholangitis (PBC) in anti-mitochondrial antibody (AMA)-negative PBC patients: a review of literature.
    de Liso F; Matinato C; Ronchi M; Maiavacca R
    Clin Chem Lab Med; 2017 Nov; 56(1):25-31. PubMed ID: 28731850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis.
    Liu H; Norman GL; Shums Z; Worman HJ; Krawitt EL; Bizzaro N; Vergani D; Bogdanos DP; Dalekos GN; Milkiewicz P; Czaja AJ; Heathcote EJ; Hirschfield GM; Tan EM; Miyachi K; Bignotto M; Battezzati PM; Lleo A; Leung PS; Podda M; Gershwin ME; Invernizzi P
    J Autoimmun; 2010 Dec; 35(4):436-42. PubMed ID: 20932720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of anti-gp210 or anti-sp100 antibodies in AMA-positive patients may help support a diagnosis of primary biliary cholangitis.
    Jaskowski TD; Nandakumar V; Novis CL; Palmer M; Tebo AE
    Clin Chim Acta; 2023 Feb; 540():117219. PubMed ID: 36610465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimitochondrial antibody-negative primary biliary cirrhosis: a subset of primary biliary cirrhosis.
    Liu B; Shi XH; Zhang FC; Zhang W; Gao LX
    Liver Int; 2008 Feb; 28(2):233-9. PubMed ID: 18251980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluctuations of antimitochondrial antibodies and anti-gp210 antibody in a patient with primary biliary cholangitis and Sjögren syndrome with subsequent autoimmune hemolytic anemia: A case report.
    Zhao DT; Liu YM; Han Y; Zhang HP; Zhao Y; Yan HP
    Medicine (Baltimore); 2020 Jan; 99(3):e18856. PubMed ID: 32011506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis assessment of GP210 and SP100 for the diagnosis of primary biliary cirrhosis.
    Hu SL; Zhao FR; Hu Q; Chen WX
    PLoS One; 2014; 9(7):e101916. PubMed ID: 25010534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming a "probable" diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: study of 100 sera and review of the literature.
    Bizzaro N; Covini G; Rosina F; Muratori P; Tonutti E; Villalta D; Pesente F; Alessio MG; Tampoia M; Antico A; Platzgummer S; Porcelli B; Terzuoli L; Liguori M; Bassetti D; Brusca I; Almasio PL; Tarantino G; Bonaguri C; Agostinis P; Bredi E; Tozzoli R; Invernizzi P; Selmi C
    Clin Rev Allergy Immunol; 2012 Jun; 42(3):288-97. PubMed ID: 21188646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical performance of AMA-M2, anti-gp210 and anti-sp100 antibody levels in primary biliary cholangitis: When detected by multiplex bead-based flow fluorescent immunoassay.
    Wang Z; Li Y; Ren L; Li Y; Xu T; Li W; Gao W; Sun G; Liu M
    Immun Inflamm Dis; 2024 Jan; 12(1):e1161. PubMed ID: 38270327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of combined anti-mitochondrial M2 detection assays for primary biliary cirrhosis.
    Han E; Jo SJ; Lee H; Choi AR; Lim J; Jung ES; Oh EJ
    Clin Chim Acta; 2017 Jan; 464():113-117. PubMed ID: 27864100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical manifestation and autoantibody profile in 123 patients with primary biliary cirrhosis].
    Liu HH; Fu JL; Xu J; Luo SQ; Liu ZW; Wang FS
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):233-7. PubMed ID: 23591343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.